Edition:
United Kingdom

H Lundbeck A/S (LUN.CO)

LUN.CO on Copenhagen Stock Exchange

408.70DKK
19 Oct 2018
Change (% chg)

kr.-6.60 (-1.59%)
Prev Close
kr.415.30
Open
kr.413.80
Day's High
kr.414.20
Day's Low
kr.408.10
Volume
170,955
Avg. Vol
320,182
52-wk High
kr.477.70
52-wk Low
kr.280.80

Select another date:

Wed, Aug 8 2018

UPDATE 1-Lundbeck drops as its adjusted profit outlook fails to impress

COPENHAGEN, Aug 8 Shares in Lundbeck dropped as much as 10 percent on Wednesday after the Danish drugmaker failed to impress the market with revisions to its full-year profit outlook.

Lundbeck Q2 beats forecast, lifts 2018 guidance

COPENHAGEN, Aug 8 Danish drugmaker Lundbeck on Wednesday posted better than expected second quarter earnings and adjusted its full-year forecast to the upper end of the earlier guidance range.

Lundbeck looks to boost drug range with new CEO

COPENHAGEN, July 2 Danish pharmaceutical company Lundbeck has picked Deborah Dunsire as its new chief executive after former CEO Kaare Schultz was poached by Teva last year.

Drugmaker Lundbeck to settle U.S. charity probe for $52.6 million

BOSTON Danish drugmaker Lundbeck said on Wednesday that it will pay $52.6 million to resolve a U.S. probe into its financial support of patient assistance charitable foundations.

UPDATE 1-Drugmaker Lundbeck to settle U.S. charity probe for $52.6 mln

BOSTON, June 6 Danish drugmaker Lundbeck said on Wednesday that it will pay $52.6 million to resolve a U.S. probe into its financial support of patient assistance charitable foundations.

Drugmaker Lundbeck to settle U.S. charity probe for $52.6 mln

BOSTON, June 6 Danish drugmaker Lundbeck said on Wednesday that it had reached a deal to pay $52.6 million to resolve a U.S. probe into its financial support of patient assistance charitable foundations.

BRIEF-H Lundbeck says FDA updates Trintellix label to include data showing improvement in processing speed

* REG-FDA UPDATES TRINTELLIX® (VORTIOXETINE) LABEL TO INCLUDE DATA SHOWING IMPROVEMENT IN PROCESSING SPEED, AN IMPORTANT ASPECT OF COGNITIVE FUNCTION IN ACUTE MAJOR DEPRESSIVE DISORDER (MDD)

Select another date: